AbbVie (ABBV), Enanta (ENTA) Active Following Gilead's (GILD) HCV Treatment Update
Go back to AbbVie (ABBV), Enanta (ENTA) Active Following Gilead's (GILD) HCV Treatment Update| AbbVie (NYSE: ABBV) | Delayed: 267.21 +2.87 (1.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $264.34 | 52 Week High | $68.12 | |||
| Open | $264.33 | 52 Week Low | $50.71 | |||
| Day High | $267.74 | P/E | 57.96 | |||
| Day Low | $263.38 | EPS | $4.61 | |||
| Volume | 1,697,443 | |||||
| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 12.42 +0.54 (4.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.88 | 52 Week High | $34.49 | |||
| Open | $11.88 | 52 Week Low | $20.39 | |||
| Day High | $12.54 | P/E | N/A | |||
| Day Low | $11.69 | EPS | $-3.18 | |||
| Volume | 214,491 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 152.26 +1.33 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.93 | 52 Week High | $108.63 | |||
| Open | $149.80 | 52 Week Low | $71.39 | |||
| Day High | $152.48 | P/E | 84.12 | |||
| Day Low | $149.41 | EPS | $1.81 | |||
| Volume | 2,447,537 | |||||

